See who we’ve worked with

With such a diverse set of requirements across the R&D life cycle, we can cut through the noise and help find the exact clients you’re looking for.

hexagon
Previous Virtual Boardrooms
BIOVIA Virtual Boardroom – 26th April 2023

BIOVIA Virtual Boardroom – 26th April 2023

Overview
WEKA Virtual Boardroom – 25th July 2023
The Vicious Data Life Cycle Management Cycle

WEKA Virtual Boardroom – 25th July 2023

Overview
Previous Virtual Boardrooms
IQVIA

IQVIA

IQVIA RBM

IQVIA RBM

IQVIA Tech

IQVIA Tech

Box

Box

ArisGlobal
De-risking Clinical Trials Virtual Boardroom

ArisGlobal

Overview
ArisGlobal
The Regulatory Landscape Virtual Boardroom

ArisGlobal

Overview
IQVIA Payments

IQVIA Payments

Sygnature Discovery

Sygnature Discovery

Drug discovery resources – what’s the most effective way to advance a project?

Nanome

Nanome

How Virtual Reality Can Positively Impact Global Drug Discovery Efforts

Sai

Sai

Developing fit-for-purpose cell-based assays for mechanistic differentiation

Contextual Genomics

Contextual Genomics

Liquid Biopsy: Is it changing the practice of precision oncology?

BioLizard

BioLizard

Next generation biomarkers: from omics to precision medicine

BC Platforms

BC Platforms

Maximizing the value of Real World Data